The real-world insights on the use, safety, and outcome of immune-checkpoint inhibitors in underrepresented populations with lung cancer von Hu, Xiao, Lin, Jeffrey H., Pan, Stacey, Salei, Yana V., Parsons, Susan K.

Volltext

Screening, Diagnosis, and Initial Care of Asian and White Patients With Lung Cancer von Hu, Xiao, Melson, John W, Pan, Stacey S, Salei, Yana V, Cao, Yu

Volltext

342 The Implications of High Expression of VISTA, a Negative Check Point Regulator, on Prognosis Across Malignant Solid Tumors: a Systematic Review and Meta-Analysis von Martin, Alexander S, Salei, Yana V, Lalla, Mumtu, Sebastiani, Paola, Morin, Rebecca A., Martell, Robert E, Trinquart, Ludovic

Volltext

PP01.67 Evaluating immune-related adverse events (irAEs) in a real-world cohort with lung cancer receiving immunotherapy von Hu, Xiao, Pan, Stacey, Salei, Yana V., Lin, Jeffrey H., Parsons, Susan K.

Volltext